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Abstract Lysine has long been recognized as an essential amino
acid for humans and the lack or low supply of this compound in
the diet may lead to mental and physical handicaps. Since lysine
is severely restricted in cereals, the most important staple food in
the world, the understanding of its biological roles must be a
major concern. Here we show that lysine is an important
precursor for de novo synthesis of glutamate, the most significant
excitatory neurotransmitter in the mammalian central nervous
system. We also show that the synthesis of glutamate from
lysine, which is carried out by the saccharopine pathway, is likely
to take place in neurons. ß 2001 Federation of European Bio-
chemical Societies. Published by Elsevier Science B.V. All
rights reserved.
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1. Introduction
Glutamate is the main excitatory neurotransmitter in the
mammalian central nervous system [1]. Although some reac-
tions leading to the synthesis of glutamate have been studied
during the last decade, the sources of nitrogen and carbon
atoms for de novo synthesis have remained elusive, as has
the involvement of astrocytes and neurons in this process
[2,3]. Glucose has been described as the main precursor of
the carbon skeleton of glutamate [4], whereas the branched-
chain amino acids (leucine, isoleucine and valine) have been
suggested as donors of amino groups for the synthesis of
V25% of the glutamate produced within the brain, by the
action of the branched-chain aminotransferase (BCAT) in as-
trocytes [5^8]. However, the amino acids which act as nitrogen
donors for the remaining 75% of the glutamate pool have not
been identi¢ed as yet.
On the other hand, several amino acids have been pointed
out as short-term precursors of glutamate, such as glutamine
[9], alanine [6,8^10] and aspartate [11]. Glutamine is synthe-
sized from glutamate in astrocytes and oligodendrocytes and
then transported into neurons, where it is reconverted to glu-
tamate [9], constituting the well-known glutamate^glutamine
cycle.
The saccharopine pathway is the main route for lysine deg-
radation in mammals [12^14] and plants [15,16], and its ¢rst
two reactions (Fig. 1) are catalyzed by enzymatic activities
known as lysine-oxoglutarate reductase (LOR) and saccharo-
pine dehydrogenase (SDH), which reside on a single bifunc-
tional polypeptide (LOR/SDH) [12,13]. LOR/SDH has been
detected in a number of mammalian tissues, mainly in the
liver and kidney, where it converts lysine into ketone bodies
[12,13], and in the rat embryonic nervous system [17]. The net
result of the sequential action of LOR and SDH is the trans-
fer of the O-amino group of lysine to glutamate (Fig. 1). This,
together with the fact that lysine is present at a high concen-
tration in the brain [18], suggested that the saccharopine path-
way could be a putative glutamate-synthesizing route in the
mammalian nervous system.
Here we show that the essential amino acid lysine, the avail-
ability of which is severely restricted in some of the world’s
major food staples, is an important precursor for de novo
glutamate production in the mammalian central nervous sys-
tem. We also show that the transfer of amino groups from
lysine to glutamate, which occurs via the saccharopine path-
way, is likely to take place in neurons.
2. Materials and methods
2.1. Tracing experiments with 15N-labeled precursors
[O-15N]L-lysine (99% atom percent excess), [K-15N]leucine (98% atom
percent excess) and [K-15N]glutamate (99% atom percent excess) were
purchased from Isotech Inc. Cerebellum and cerebral cortex slices
from 2 months old C57/Black6 mice were prepared and incubated
with 15N-labeled precursors according to previous studies [6]. Labeled
leucine and glutamate were used at ¢nal concentrations of 300 WM, as
described by Yudko¡ et al. [8]. Labeled lysine was also used at a ¢nal
concentration of 300 WM because its concentration in the central
nervous system has been shown to be similar to that of leucine [18].
Sample preparation and analysis by gas chromatography-mass
spectrometry (GC-MS) were performed as previously reported [8],
using a Hewlett-Packard 5971 GC-MS system and a 12 mU0.32
mm DB-5 capillary also from Hewlett-Packard. Ion ratios for gluta-
mate and leucine were as detailed elsewhere [8] and di¡erent ion ratios
were used for lysine (m/z 174/175, 317/318 and 431/432) to analyze its
K- and O-amino groups separately. The percentage 15N-enrichment
(‘atom percent excess’ or APE), corrected for the natural abundances
of the isotopes, was determined from those mass ratios [6]. The higher
the APE of a given compound, the larger the percentage of its mol-
ecules which are labeled with 15N.
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2.2. RT-PCR and RNA gel blot analyses
Mouse brain and cerebellum RNAs were extracted from 2 months
old C57/Black6 animals as previously described [12]. Reverse tran-
scription (RT) was carried out with Superscript II (Gibco BRL), as
recommended in the manufacturer’s protocol. Oligonucleotides 5P-
TAT GGG ACG GTG TTA AGT CGC-3P and 5P-AAA ATC TAT
GGA CCC TCC CGT-3P, which yield a 300 bp fragment of the mouse
LOR/SDH cDNA (GenBank accession number NM013930), were
used for the consecutive PCR (1 min at 94‡C, 1.5 min at 62‡C,
2 min at 72‡C; 27 cycles). Oligonucleotides 5P-GGC TGT ATT
CCC CTC CAT CGT-3P and 5P-GAG CCA CCG ATC CAC ACA
GAG-3P were used to amplify L-actin as an internal control. Bands
were quanti¢ed on a FLA-3000 Fluorescent Image Analyzer (Fuji-
¢lm). Human multiple tissue poly(A) Northern blots (Fig. 3b,c) con-
taining RNA samples from donors of varying ages and sex were
purchased from Clontech (#7755-1; #7756-1) and hybridized with
an SDH-speci¢c probe, corresponding to nucleotides 1540^2235 of
the human LOR/SDH cDNA (GenBank NM005763).
2.3. In situ hybridization
Digoxigenin-labeled antisense and sense run-o¡ transcripts were
synthesized using a DIG-labeling kit (Boehringer-Mannheim) and a
PCR fragment containing 300 bp of the mouse LOR/SDH cDNA
(bases 800^1112), which was £anked by T3 and T7 RNA polymerase
promoters. In situ hybridization was performed on freshly cut cryo-
sections (10^12 Wm) of brain and cerebellum from C57/Black6 animals
[19]. Probe concentrations were V200 ng/ml of hybridization bu¡er.
Hybridized labeled probes were visualized using alkaline phosphatase-
coupled anti-digoxigenin Fab fragments (Boehringer-Mannheim) with
BCIP/NBT as substrate [19]. Light microscope images were acquired
using Ektachrome slide ¢lm (Kodak), which was then scanned at high
resolution on a SprintScan 35 Plus (Polaroid) and processed electroni-
cally for photo-quality hard printing using a KDS 8650 digital printer
(Kodak).
3. Results
3.1. Lysine is the precursor of a large proportion of glutamate
in the mouse nervous system
To de¢nitely establish the occurrence of the saccharopine
pathway in the mammalian brain and to verify which fraction
of the glutamate pool in the nervous system is actually derived
from lysine via the LOR/SDH-catalyzed reactions, slices of
cerebral cortex and cerebellum were incubated with 15N-la-
beled lysine (Fig. 2). These incubations were done with lysine
labeled in its O-amino group so as to examine the fate of this
group alone and, consequently, the participation of LOR/
SDH (Fig. 1). In the cerebellum, as expected, labeled lysine
was rapidly taken up by the slices: Its isotopic enrichment
(APE) reached 40% after 1 h of incubation (Fig. 2a), decreas-
ing afterwards due to the transfer of its 15N-label to other
cellular compounds. Glutamate 15N-labeling rapidly reached
a mean value of approximately 12% APE (Fig. 2a) and was
already detectable after 10 min of incubation (Fig. 2a, inset).
The results obtained for the cerebral cortex slices were similar
(Fig. 2d), although the labeling of glutamate from lysine was
lower than in slices from cerebellum (Fig. 2a). Since the in-
cubations were done with lysine concentrations similar to
those normally found in the brain extracellular £uid, these
results indicate that approximately 33% (40/12) of all gluta-
mate in the central nervous system is likely to be derived from
lysine via LOR/SDH. This value could be an underestimate,
since the transfer of the K-amino group from lysine to gluta-
mate, which proceeds through the pipecolate pathway (Fig. 1)
[20], was not assessed. Hence, lysine is probably a major nitro-
gen donor for glutamate synthesis in the mammalian central
nervous system.
Cerebral cortex and cerebellum slices were also incubated
with 15N-labeled glutamate to examine the reversibility of the
LOR/SDH-catalyzed reactions (Fig. 2b,e). Although 15N-la-
beling of lysine at its K-amino group was detected (Fig.
2b,e), indicating reversibility of the reaction which catalyzes
the conversion of lysine into 2-keto-6-aminocaproate in the
pipecolate pathway (Fig. 1), no labeling of lysine at its
O-amino group was observed. This ¢nding suggests that the
reactions catalyzed by LOR and SDH speed the conversion of
lysine into glutamate up. As a control, the same set of incu-
bations was performed with 15N-labeled leucine (Fig. 2c,f) and
reproduced already published data showing the production of
glutamate from leucine via the enzyme BCAT [8].
3.2. The gene encoding the lysine-degrading enzyme LOR/SDH
is conspicuously expressed in the mammalian central
nervous system
We have previously isolated cDNAs encoding the mouse
Fig. 1. Lysine catabolic routes in higher eukaryotes. The ¢rst two
reactions of the saccharopine pathway (left) are catalyzed by the
concerted activities of LOR and SDH, the net result of which is the
transfer of the O-amino group of lysine to 2-oxoglutarate, resulting
in the synthesis of glutamate. The transfer of the K-amino group of
lysine (marked by an asterisk) to glutamate occurs through the pipe-
colate pathway (right). The compound 2-aminoadipate semialde-
hyde, common to both routes, may be further degraded to acetyl-
CoA through a series of reactions (broken lines), although the enzy-
matic activities involved have not been shown to occur in the brain
yet.
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[12] and human LOR/SDH. These cDNAs were used in the
analysis of LOR/SDH mRNA expression to demonstrate the
occurrence of the saccharopine pathway in the mammalian
central nervous system (Fig. 3). There was signi¢cant expres-
sion of LOR/SDH in the mouse cerebral cortex and cerebel-
lum, with less prominent expression in the hypophyseal gland
and in immature embryonic brain (Fig. 3a). In the cerebellum,
the expression was even comparable to that in the liver (Fig.
3a). Expression in the cerebral cortex was lower than in the
cerebellum, in agreement with the 15N.data (Fig. 2). LOR/
SDH expression also occurred in several regions of the human
nervous system (Fig. 3b), paralleling the results obtained for
mouse (Fig. 3a), with stronger expression in the occipital and
frontal lobes and in the cerebellum. Expression was also evi-
dent in human embryonic tissues, including brain (Fig. 3c).
3.3. LOR/SDH is located in several regions of the mouse
cerebellum, particularly in neurons
In situ hybridization was used to further investigate which
regions and cell types of the brain and cerebellum express
LOR/SDH (Fig. 4). LOR/SDH expression was found in al-
most every region of the adult mouse central nervous system,
which was in keeping with results described in Fig. 3. The
highest expression was seen in the cerebellum, with the gran-
ular and molecular cell layers showing lower staining and the
Purkinje cell layer possessing the strongest staining (Fig. 4a^
c). In the latter, the staining appeared to be concentrated in
neuronal (Purkinje) cells (Fig. 4d, as compared with a Nissl-
stained control section in Fig. 4e). There was no detectable
expression of LOR/SDH in the cerebellar white matter (Fig.
4a). The hippocampus had conspicuous expression of LOR/
SDH (Fig. 4f), mainly in the CA1 region, and less signi¢cantly
in the CA3 region and dentate gyrus. The cerebral cortex also
showed strong LOR/SDH expression (Fig. 4g,h), although
somewhat less prominent than that in the cerebellum, in
agreement with the RT-PCR results (Fig. 3a). There was no
di¡erence in the staining of the several gray matter cortical
layers, and the white matter showed no staining at all (Fig.
4g), a ¢nding similar to that seen in the cerebellum (Fig. 4a).
In the brainstem, several nuclei possessed strong LOR/SDH
expression (Fig. 4i) and, as in the cerebellum, the staining
Fig. 2. Metabolism of 15N-labeled amino acids in the brain and cerebellum. Slices of cerebellum (a^c) or cerebral cortex (d^f) were incubated
with 15N-labeled lysine (a,d), glutamate (b,e) or leucine (c,f) to assess the role of lysine as a precursor of glutamate in the mammalian brain.
The percent 15N-enrichment (atom percent excess) indicates the isotopic enrichment measured in a given amino group, namely the O-amino
group of lysine (¢lled circles), the K-amino group of lysine (¢lled squares), and the amino groups of glutamate (open circles) and leucine (¢lled
triangles). Insets in a and d show earlier time points for incubations with lysine. Bars denote the S.E.M. of four independent experiments (slices
obtained from four animals).
Fig. 3. Expression of LOR/SDH in the mammalian central nervous
system. a: RT-PCR analysis showing the expression of LOR/SDH
in mouse embryonic brain (stages E13^E19) and adult brain (Cbl,
cerebellum; Ctx, cerebral cortex; Hyp, hypophyseal gland) com-
pared to adult liver (Li) and skeletal muscle (Sm). b,c: Northern
blot analysis showing the expression of LOR/SDH in human adult
brain (b) and human embryo (c). Md, medulla; Sc, spinal cord; Oc,
occipital pole; Fr, frontal lobe; Tm, temporal lobe; Pt, parietal
lobe; Br, brain; Lg; lung; Kd, kidney. The 9.5 kb and 7.4 kb
bands represent distinct LOR/SDH transcripts [12,29]. The bottom
panels in b and c represent control hybridizations of the corre-
sponding blots with a GAPDH probe.
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seemed to be located mainly in neurons (Fig. 4j), although
concomitant expression in glia could not be ruled out. The
detection of LOR/SDH in neuronal cells suggests that the
saccharopine pathway may be a de novo glutamate-synthesiz-
ing route for neurons, in contrast to the BCAT-catalyzed
glutamate synthesis, which seems to be restricted to astrocytes
[2,3,5].
4. Discussion
Our data show the widespread distribution of the lysine-
degrading enzyme LOR/SDH in the mammalian central nerv-
ous system and indicate that lysine is an important precursor
of the neurotransmitter glutamate (via LOR/SDH) in several
brain regions, in adult as well as in embryo. This biosynthesis
Fig. 4. In situ hybridization showing the expression of LOR/SDH in the mouse central nervous system. a,b: Cerebellum sections hybridized
with LOR/SDH antisense (a) and sense (b) probes, showing conspicuous staining in the Purkinje (arrow, pcl), molecular (mcl) and granule (gcl)
cell layers. The region delimited by the yellow box in a is shown at a higher magni¢cation in d, and illustrates the expression of LOR/SDH in
Purkinje neurons (arrows). c,e: Nissl-stained control sections of a and d, respectively. f : Expression in the hippocampus and in the thalamus
(thl), showing strong staining in the CA1 region and less staining in the CA3 region and dentate gyrus (dtg). g,h: Cerebral cortex sections hy-
bridized with LOR/SDH antisense (g) and sense (h) probes, showing uniform expression throughout cortical layers. i : Several brainstem (bst)
nuclei with strong expression of LOR/SDH (arrows), mostly in neurons, as detailed in j (a higher magni¢cation of the yellow-boxed region in
i). Scale bars in a^c,f^i: 100 Wm; scale bars in d,e,h: 21.5 Wm. Other abbreviations: fvt, fourth ventricule; ccl, corpus callosum; lvt, lateral ven-
tricle.
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was shown to occur in neurons and it is the ¢rst time a de
novo glutamate-synthesizing route has been ascribed to these
cells. Moreover, this represents a glutamate synthesis which is
independent of the astrocytic glutamate^glutamine cycle. GA-
BAergic neurons may also use this route to produce GABA
since this neurotransmitter is derived directly from glutamate
[9]. Glutamate-mediated neurotransmission is essential for the
proper functioning of the central nervous system and is espe-
cially required during brain maturation and immediately after
birth, when most cellular communications are being estab-
lished and re¢ned [1,21^23]. Any substances associated with
the production of glutamate in these phases will thus be es-
sential, and their absence may probably result in brain mal-
functioning. Indeed, lysine has long been recognized as an
essential amino acid, the lack or low supply of which may
lead to mental and physical retardations [24^27]. This seems
to be a very important issue since the lysine content of cereals,
the most consumed staple food in the world, is severely re-
stricted. Thus, the results described here provide a link be-
tween glutamate synthesis, neurotransmission, nervous system
development and nutritional requirement for lysine.
Moreover, since glutamate is involved in a number of ex-
citatory brain injuries, such as those associated with stroke,
hypoglycemia, epilepsy and ischemia [1,28,29], LOR/SDH
may turn into an important molecular target for the preven-
tion and therapy of such damages. Lastly, LOR/SDH has
been implicated in several kinds of human familial hyperlysi-
nemias [30], some of them frequently accompanied by severe
physiological and morphological defects in the nervous sys-
tem, which will be better understood and treated upon further
studies on the human and mouse LOR/SDH and on their
participation in glutamate synthesis in the brain.
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